NMR STRUCTURE-BASED DRUG DESIGN

被引:42
作者
FESIK, SW
机构
[1] Pharmaceutical Discovery Division D-47G, AP9 Abbott Laboratories, Abbott Park, 60064, IL
关键词
DRUG DESIGN; MOLECULAR MODELING; 3D DATABASE SEARCHING; HETERONUCLEAR MULTIDIMENSIONAL NMR;
D O I
10.1007/BF00212513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NMR is a useful tool for rapidly determining the conformations of receptor-bound ligands and identifying those protions of the ligand in contact with the receptor. In addition, the complete 3D structures of receptors and ligand/receptor complexes can be obtained using recently developed heteronuclear multi-dimensional NMR techniques. This NMR-derived structural information is potentially useful for aiding in the design of improved pharmaceutical agents. Approaches for utilizing the NMR-derived structural information along with the computational tools that facilitate this process are discussed.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 71 条
[1]   USE OF TRANSFERRED NUCLEAR OVERHAUSER EFFECTS IN THE STUDY OF THE CONFORMATIONS OF SMALL MOLECULES BOUND TO PROTEINS [J].
ALBRAND, JP ;
BIRDSALL, B ;
FEENEY, J ;
ROBERTS, GCK ;
BURGEN, ASV .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1979, 1 (01) :37-41
[2]   THE DEVELOPMENT OF VERSION-3 AND VERSION-4 OF THE CAMBRIDGE STRUCTURAL DATABASE SYSTEM [J].
ALLEN, FH ;
DAVIES, JE ;
GALLOY, JJ ;
JOHNSON, O ;
KENNARD, O ;
MACRAE, CF ;
MITCHELL, EM ;
MITCHELL, GF ;
SMITH, JM ;
WATSON, DG .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1991, 31 (02) :187-204
[3]   MAGNETIC-RESONANCE OF A MONOCLONAL ANTI-SPIN-LABEL ANTIBODY [J].
ANGLISTER, J ;
FREY, T ;
MCCONNELL, HM .
BIOCHEMISTRY, 1984, 23 (06) :1138-1142
[4]   DESIGN OF ENZYME-INHIBITORS USING ITERATIVE PROTEIN CRYSTALLOGRAPHIC ANALYSIS [J].
APPELT, K ;
BACQUET, RJ ;
BARTLETT, CA ;
BOOTH, CLJ ;
FREER, ST ;
FUHRY, MAM ;
GEHRING, MR ;
HERRMANN, SM ;
HOWLAND, EF ;
JANSON, CA ;
JONES, TR ;
KAN, CC ;
KATHARDEKAR, V ;
LEWIS, KK ;
MARZONI, GP ;
MATTHEWS, DA ;
MOHR, C ;
MOOMAW, EW ;
MORSE, CA ;
OATLEY, SJ ;
OGDEN, RC ;
REDDY, MR ;
REICH, SH ;
SCHOETTLIN, WS ;
SMITH, WW ;
VARNEY, MD ;
VILLAFRANCA, JE ;
WARD, RW ;
WEBBER, S ;
WEBBER, SE ;
WELSH, KM ;
WHITE, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (07) :1925-1934
[5]   THIENOTHIOPYRAN-2-SULFONAMIDES - NOVEL TOPICALLY ACTIVE CARBONIC-ANHYDRASE INHIBITORS FOR THE TREATMENT OF GLAUCOMA [J].
BALDWIN, JJ ;
PONTICELLO, GS ;
ANDERSON, PS ;
CHRISTY, ME ;
MURCKO, MA ;
RANDALL, WC ;
SCHWAM, H ;
SUGRUE, MF ;
SPRINGER, JP ;
GAUTHERON, P ;
GROVE, J ;
MALLORGA, P ;
VIADER, MP ;
MCKEEVER, BM ;
NAVIA, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) :2510-2513
[6]   SIMPLIFICATION OF TWO-DIMENSIONAL NOE SPECTRA OF PROTEINS BY C-13 LABELING [J].
BAX, A ;
WEISS, MA .
JOURNAL OF MAGNETIC RESONANCE, 1987, 71 (03) :571-575
[7]   NMR OF PROTONS COUPLED TO C-13 NUCLEI ONLY [J].
BENDALL, MR ;
PEGG, DT ;
DODDRELL, DM ;
FIELD, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (04) :934-936
[8]   THE COMPUTER-PROGRAM LUDI - A NEW METHOD FOR THE DENOVO DESIGN OF ENZYME-INHIBITORS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (01) :61-78
[9]  
BURES MG, 1990, TETRAHEDRON COMP MET, V3, P673
[10]   4-DIMENSIONAL C-13/C-13-EDITED NUCLEAR OVERHAUSER ENHANCEMENT SPECTROSCOPY OF A PROTEIN IN SOLUTION - APPLICATION TO INTERLEUKIN 1-BETA [J].
CLORE, GM ;
KAY, LE ;
BAX, A ;
GRONENBORN, AM .
BIOCHEMISTRY, 1991, 30 (01) :12-18